Chronic oral defibrotide counteracts hypercholesterolemia noxious effects on cardiovascular function in the rabbit

Thrombosis Research

Volumn 94, Issue 5, 1999, Pages 327-338

  Rossoni, Giuseppe ^a   Berti, Ferruccio ^a   Trento, Fabio ^b   Cattaneo, Franco ^b   Porta, Roberto ^b   Pescador, Rodolfo ^b   Ferro, Laura ^b  

^a Univ M   (Italy)

^b Crinos Biological Research Laboratories   (Italy)

Author keywords

Atherosclerosis; Endothelial disfunction; Endothelial protection; Heart function; Hypercholesterolemia; Inflammation; Oxidative stress

Indexed keywords

ACETYLCHOLINE; DEFIBROTIDE; ENDOTHELIN 1; NORADRENALIN BITARTRATE;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR FUNCTION; CELL PROTECTION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; HEART FUNCTION; HYPERCHOLESTEROLEMIA; INFLAMMATION; NOCICEPTIVE STIMULATION; NONHUMAN; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RABBIT;

6-KETOPROSTAGLANDIN F1 ALPHA; ADMINISTRATION, ORAL; ANIMALS; AORTA; BLOOD PRESSURE; CHOLESTEROL, DIETARY; FIBRINOLYTIC AGENTS; HEART; HYPERCHOLESTEROLEMIA; MYOCARDIUM; POLYDEOXYRIBONUCLEOTIDES; RABBITS; VASOCONSTRICTION; VENTRICULAR FUNCTION, LEFT;

EID: 0033152194     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00009-2     Document Type: Article

References (42)

1. Ross R. The pathogenesis of atherosclerosis. A perspective for the 1990s Nature. 362:1993;801-809.
2. Lefer A.M., Sedar A.W. Endothelial alterations in hypercholesterolemia and atherosclerosis. Pharmacol Res. 23:1991;1-12.
3. Busse R., Fleming I. Endothelial dysfunction in atherosclerosis. J Vasc Res. 33:1996;181-194.
4. Lerman A., Burnett J.C. Jr. Intact and altered endothelium in regulation of vasomotion. Circulation. 86(Suppl 6):1992;III12-III19.
5. Winkles J.A., Alberts G.F., Brogi E., Libby P. Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries. Biochem Biophys Res Commun. 191:1993;1081-1088.
6. Berti F., Rossoni G., Niada R., Folco G., Omini C., Tondo C. Defibrotide, an antithrombotic substance that preserves postsynaptic alfa and beta-adrenergic function in post acute infarcted rabbit hearts. J Cardiovasc Pharmacol. 8:1986;235-240.
7. Löbel P., Schrör K. Selective stimulation of coronary vascular PGI2 but not of platelet thromboxane formation by Defibrotide in the platelet perfused heart. Naunyn Schmiedebergs Arch Pharmacol. 331:1985;125-130.
8. Berti F., Rossoni G., Omini C., Folco G.C., Daffonchio L., Viganò T., Tondo C. Defibrotide, an antithrombotic substance which prevents myocardial contracture in ischemic rabbit heart. Eur J Pharmacol. 135:1987;375-382.
9. Berti F., Rossoni G., Magni F., Caruso D., Omini C., Puglisi L., Galli G. Nonsteroidal antiinflammatory drugs aggravate acute myocardial ischemia in the perfused rabbit heart. A role for prostacyclin J Cardiovasc Pharmacol. 12:1988;438-444.
10. Berti F., Magni F., Rossoni G., De Angelis L., Galli G. Production and biologic interactions of prostacyclin and platelet-activating factor in acute myocardial ischemia in the perfused rabbit heart. J Cardiovasc Pharmacol. 16:1990;727-732.
11. Berti F., Rossoni G., Della Bella D., Villa L.M., Buschi A., Trento F., Berti M., Tondo C. Nitric oxide and prostacyclin influence coronary vasomotor tone in perfused rabbit heart and modulate endothelin-1 activity. J Cardiovasc Pharmacol. 22:1993;321-326.
12. Rossoni G., Sala A., Buccellati C., Maclouf J., Folco G.C., Berti F. Vasoconstriction to polymorphonuclear leukocytes in the isolated, perfused rabbit heart. Inhibition by prostacyclin mimetics J Cardiovasc Pharmacol. 27:1996;680-685.
13. Lefer A.M., Aoki N., Mulloy D. Coronary-endothelium protective effects of Defibrotide in ischaemia and reperfusion. Naunyn Schmiedebergs Arch Pharmacol. 341:1990;246-250.
14. Thiemermann C., Löbel P., Schrör K. Usefulness of Defibrotide in protecting ischemic myocardium from early reperfusion damage. Am J Cardiol. 56:1985;978-982.
15. Niada R., Porta R., Pescador R., Mantovani M., Prino G. Protective activity of Defibrotide against lethal acute myocardial ischemia in the cat. Thromb Res. 42:1986;363-374.
16. Niada R., Porta R., Pescador R., Mantovani M., Prino G. Cardioprotective effects of Defibrotide in acute myocardial ischemia in the cat. Thromb Res. 38:1985;71-81.
17. Thiemermann C., Thomas G.R., Vane J.R. Defibrotide reduces infarct size in a rabbit model of experimental myocardial ischaemia and reperfusion. Br J Pharmacol. 97:1989;401-408.
18. Schrör K., Ackermann G., Hohlfeld Th Löbel P., Ney P., Schröder H., Strobach H. Endothelial protection by Defibrotide - a new strategy for treatment of myocardial infarction? Z Kardiol. 78(Suppl 6):1989;35-41.
19. Hohlfeld Th Strobach H., Schrör K. Stimulation of prostacyclin synthesis by Defibrotide. Improved contractile recovery from myocardial "stunning" J Cardiovasc Pharmacol. 17:1991;108-115.
20. Hohlfeld Th Strobach H., Schrör K. Stimulation of endogenous prostacyclin protects the reperfused pig myocardium from ischemic injury. J Pharmacol Exp Ther. 264:1993;397-405.
21. Pescador R., Porta R., Conz A., Mantovani M., Prino G. Defibrotide decreases cholesterol amount in hypercholesterolemic rabbit aorta, with no modification of plasma or lipoprotein cholesterol. Life Sci. 44:1989;789-797.
22. Löbel P., Schrör K. Stimulation of vascular prostacyclin and inhibition of platelet function by oral Defibrotide in cholesterol-fed rabbits. Atherosclerosis. 80:1989;69-79.
23. Porta R., Conz A., Conto A., Pescador R., Mantovani M., Ferro L. Comparable beneficial effects of Defibrotide and Nifedipine in calcium induced atherosclerosis. Life Sci. 54:1994;799-812.
24. Pescador R., Tettamanti R., Salvetti L., Conto A., Barone D., Porta R., Mantovani M., Ferro L. Effects of Defibrotide on leukocytosis in rabbits with diet-induced atherosclerosis. Life Sci. 57:1995;579-589.
25. Bøyum A., Løvhaug D., Tresland L., Nordlie E.M. Separation of leucocytes. Improved cell purity by fine adjustments of gradient medium density and osmolality Scand J Immunol. 34:1991;697-712.
26. 2 receptor mediated? Pharmacol (Life Sci Adv). 14:1995;123-126.
27. Schierwagen C., Bylund-Fellenius A.C., Lunderberg C. Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity. J Pharmacol Meth. 23:1990;179-186.
28. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
29. Rossoni G., Berti F., Bernareggi M., Villa L., Agozzino S., Cereda R., Giuliani P., Mizrahi J. Protective effects of ITF 296 in the isolated rabbit heart subjected to global ischemia. J Cardiovasc Pharmacol. 26(Suppl 4):1995;S44-S52.
30. Pradelles P., Grassi J., Maclouf J. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label. An alternative to radioimmunoassay Anal Chem. 57:1985;1170-1173.
31. Lefer A.M., Ma X.L. Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium. Arterioscler Thromb. 13:1993;771-776.
32. Lorant D.E., Patle K.D., McIntyre T.M., McEver R.P., Prescott S.M., Zimmerman G.A. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin. A juxtacrine system for adhesion and activation of neutrophils J Cell Biol. 115:1991;223-234.
33. Scalia R., Kochilas L., Campbell B., Lefer A.M. Effects of Defibrotide on leukocyte-endothelial cell interaction in the rat mesenteric vascular bed. Role of P-selectin Methods Find Exp Clin Pharmacol. 18:1996;669-676.
34. Mannaioni P.F., Di Bello M.G., Masini E. Platelets and inflammation. Role of platelet-derived growth factor, adhesion molecules and histamine Inflamm Res. 46:1997;4-18.
35. Cooke J.P., Singer A.H., Tsao P., Zera P., Rowan R.A., Billingham M.E. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 90:1992;1168-1172.
36. Schrör K. Cytoprotection by prostacyclins in myocardial ischemia. Zor U., Naor Z., Danon A. New Trends Lipid Mediators Research, vol. 3. 1989;246-251 Karger, Basel.
37. Smith E.F. III, Kloster G., Stöcklin G., Schrör K. Effect of iloprost (ZK 36374) on membrane integrity in ischemic rabbit hearts. Biomed Biochim Acta. 43:1984;S155-S158.
38. Darius H., Osborne J.A., Reibel D.A., Lefer A.M. Protective actions of a stable prostacyclin analog in ischemia induced membrane damage in rat myocardium. J Mol Cell Cardiol. 19:1986;243-250.
39. Çizmeci G. In vivo effects of Defibrotide on platelet c-AMP and blood prostanoid levels. Haemostasis. 16(Suppl 1):1986;31-35.
40. Habib J.B., Bossaller C., Wells S., Williams C., Morrisett J.D., Henry P.D. Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium blocker PN 2001-10. Circulation Res. 58:1986;305-309.
41. Verbeuren T.J., Coene M.-C., Jordaens F.H., Van Hove C.E., Zonnekeyn L.L., Herman A.G. Effect of hypercholesterolemia on vascular reactivity in rabbit. II. Influence of treatment with dipyridamole on endothelium-dependent and endothelium-independent responses in isolated aortas of control and hypercholesterolemic rabbits. Circulation Res. 59:1986;496-504.
42. Osborne J.A., Lento P.H., Siegfried M.R., Stahl G.L., Fusman B., Lefer A.M. Cardiovascular effects of acute hypercholesterolemia in rabbits. Reversal with lovastatin treatment J Clin Invest. 83:1989;465-473.